Tuesday - June 9, 2026
University College London: Weight Loss Drug Semaglutide Helps Patients Who Do Not Respond to Bariatric Surgery
May 22, 2026
LONDON, England, May 22 (TNSjou) -- The University College London posted the following news:

* * *

Weight loss drug semaglutide helps patients who do not respond to bariatric surgery

New UCL research supports use of the weight loss drug semaglutide for patients who do not get enough benefit from bariatric surgery.

Metabolic/bariatric surgery is a highly effective treatment for people living with severe obesity and/or metabolic health conditions . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products